0.56; 95%CI [0.33-0.95]). Subgroup analysis including only OSA showed a similar result after adjustement (p=0.017; HR: 0.40;). In multivariate cox analysis including all the polygraphic variables, only CSR and minimal oxyhemoglobin saturation predicted adverse outcomes in all CHF patients untreated for SDB but AHI.
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Metaboreflex attenuation as a potential cause of improvement in the ventilatory response after cardiac resynchronization therapy Jérémie Jaussaud [Orateur] , Laurie Aimable, Pierre Bordachar, Raymond Roudaut, Hervé Douard CHU Bordeaux, Bordeaux, France Background: Patients suffering from heart failure (HF) have constant exaggerated hyperventilation (high VE/VCO2) leading to breathlessness and reduced exercise capacity. Metaboreflex over activation has been proposed to partly explain this high ventilatory response during exercise.
Objective: We aim to investigate the modification of the metaboreflex activation as a determinant in the improvement of the ventilatory response 6 months after CRT.
Methods and results: 10 HF patients (mean left ventricular ejection (LVEF) 27±4%, peak VO2 14±4 ml/kg/min, NYHA class 2,6±0,5; QRS duration >120 ms) schedulded for CRT implantation were prospectively studied. At baseline and after 6 month follow up two maximal cardiopulmonary exercise tests with and without regional circulatory occlusion (RCO) were performed with continuous VE, respiratory ratio (RR), VCO2 and VO2 measurements. RCO was achieved by inflation of bilateral upper thigh tourniquets 30 mmHg above peak systolic blood pressure during 3 minutes after peak exercise as previously described. Metaboreflex contribution to the ventilatory response was assessed as the difference in ventilatory data at the third minute during recovery between the two tests (RCO -no RCO='). At baseline, patients had enhanced VE/VCO2 slope (40±9) and an evident metaboreflex contribution to the high ventilatory response ('VE: 3±4 L/min; p=0.01, 'RR: 4.5±4/min; p=0.01). 6 months after CRT implantation, NYHA class, LVEF, peak VO2 and VE/VCO2 were significantly improved (1,5±0,5; p<0.001, 42±7%; p<0.001, 16±4 ml/kg/min; p=0.005; 33±9; p=0.001). Metaboreflex contribution to ventilation was reduced compared with baseline ('VE: -1±5; p=0.08, 'RR: -1±3; p=0.01).
Conclusion: 6 months after CRT metaboreflex contribution to ventilation is reduced and appears as an explanation in the ventilatory response improvement in HF population.
Tricuspid regurgitation changes after cardioverter-defibrillator implantation: a prospective study
Colette Rio [Orateur], Pierre Nazeyrollas, Angeline Martin, Raphael Sandras, François Lesaffre, Sophie Tassan-Mangina, Benoit Hercé, Jean Pierre Chabert, Damien Metz CHU Reims, Cardiologie, Reims Cedex, France Introduction: it remains controversial whether pacemaker lead implantations could interfere with tricuspid valve function. The use of rigid and thicker ventricular leads with implantable cardioverter-defibrillators (ICD) may increase this risk. We realised a prospective study to analyse the tricuspid valve function in this setting.
Method: we included patients needing a first ICD between october 2009 and may 2010 and performed echocardiographic recordings the day before implantation, during the 3 following days and at 6 weeks. These records were analysed offline independently by 2 cardiologists to assess and grade tricuspid valve regurgitation (TR) using PISA and semi-quantitative method, and to measure ventricular dimensions, function and pressures.
Results: we included 32 patients, 29 males, aged 61±14. Hypokinetic cardiopathy accounted for 26 and 24 were implanted for primary prevention. Ejection fraction was 35±14 %. Non significant TR was found in 23 patients and only 2 patients has a tricuspid regurgitation greater than mild. The only significant changes occurring immediately after defibrillator implantation concerned TR, with a mean volume raising from 3.1±3.2 ml to 6.1±7.0 ml (p<0.01) and a ROS from 0.03±0.3 to 0.06±0.07 cm² (p<0.01). Six TR changed from not significant to minime (3) or mild (3), 3 from minime to mild. Two patients with a baseline mild TR raised the regurgitant volume from 11 ml to 19 ml and 30 ml. Mean regurgitant fraction increased from 5.5% to 10.5% and was higher in patients with a low ejection fraction and mild TR at baseline. At 6 weeks, the results were similar. From a clinical standpoint, no death occurred, and no worsening of heart failure was noticed.
Conclusion: we found a significant but minor increase in TR after defibrillator implantation, with no foreseeable consequences. However, our data hint that this increase may be relevant in patients with the greater baseline regurgitation and the lower cardiac output
Heart failure patterns in Djibouti (Horn of Africa): an epidemiologic transition perspective
Pierre-Laurent Massoure [Orateur] (1), Eric Kaiser (1), Gatien Lamblin (1), François Topin (1), Olivier Eve (1), Celine Dehan (1), Laurent Fourcade (2) (1) Hôpital Bouffard, Djibouti, Djibouti -(2) Hôpital d'Instruction des Armées Alphonse Laveran, Cardiologie, Marseille, France Purpose: Cardiovascular disease patterns are changing in Africa. We aimed to document the current heart failure (HF) patterns in Djibouti.
Methods: We prospectively included Djiboutian adults hospitalized for HF in the French Military Hospital (Djibouti) between August 2008 and December 2010. Clinical and prognosis data were recorded.
Results: Among 1688 adults hospitalized in the medicine department, 45 (2.7%) had symptomatic HF: 38 (84%) males, mean age 55.8 years (range 27-75). Twenty five (56%) patients were initially hospitalized for acute pulmonary oedema. New York Heart Association (NYHA) class was 2 (40%), 3 (44%) and 4 (16%) one month after discharge from hospital. Underlying disease was coronary artery disease (CAD) (62%) including previous myocardial infarction (83% of patients with CAD), hypertensive heart disease (18%), rheumatic valvular disease (13%) and primitive dilated cardiomyopathy (7%). Cardiovascular risk factors were tobacco use (53%), hypertension (69%), diabetes (47%) and hypercholesterolemia (51%). In the CAD group, patients were older and diabetes was more frequent (p<0.01). Khat chewers (53%) were all males and smokers. Severe renal failure was found in 20%. Mean left ventricular ejection fraction (LVEF) was 39±14%. Atrial fibrillation was observed in 7%. During follow up (14.4±9 months), 8 (18%) patients died, 9 (20%) had new hospitalization for HF and 3 (7%) had an ischemic stroke. Higher NYHA classes were associated with poorer outcomes (p= 0.03). Patients with LVEF d35% (n=24, 53%), were compared with patients with LVEF >35% and no difference was observed in terms of risk factors, underlying disease and outcome.
Conclusion: In hospitalized Djiboutian, most of HF patterns are similar to those of industrialized countries. CAD is more prevalent than previously reported in African patients with HF. Epidemiologic transition is a reality in Djibouti. Urgent measures for the prevention of cardiovascular disease and HF are needed. Approximately 20% of heart failure patients have low levels of serum sodium, often at a time when they are hospitalized during a period of decompensation. It may reflect worsening heart failure and the deleterious effects of activation of neurohormones. However, impact of hypernatremia, prognostically relevant cut-off values, and differential prognosis with reference range serum sodium levels are not well defined.
Methods: Our aim was to prospectively assess the impact of baseline natremia and changes in sodium level during median follow-up of 32 months in 1509 patients. According to our central laboratory, hypo-and hypernatremia were defined as sodium levels <135 and >145 mmol/l. Chi2 test was used, a difference was statistically considered significant if p<0.05.
Results: The prevalence of Hyponatremia was 12.45% and hypernatremia was 0.9%. The mean age was 64.32 years (20-97), with a male predominance (68.15%).There was a correlation between value of sodium levels and severity of heart failure. The positive correlates of hyponatremia compared with normonatremia were NYHA functional class [we find class III in 32.9% patients vs 18.5% (p=0.0089) and class IV in 7.9% vs 2.09% (p=0.0075)], decompensation found in 26.5% patients vs 12.04% (p=0.0085), renal dysfunction: mean creatinine was at 15 vs 10mg per litre (p=0.0015), use of high dose of diuretics 61.17% vs 40.46% (p=0.0012) and use of spironolactone 81,38% vs 51,50%(p=0.0082). Positive correlates of hypernatremia were intake of diuretics 54.8% vs 40.46% (p=0.001), NYHA functional class [72.78% were in class II vs 61.03% and 27.22% were in class III vs 18.5% (p=0.002 )], decompensation in 38.8% vs 12.04% (p=0;001) Conclusion: The severity of heart failure, the renal function and medication were associated with serum sodium levels. Our data indicate the need of further research into optimized management of sodium-water homeostasis in heart failure.
